STUDY OF ORGANON IN PATIENTS WITH PARTIAL SEIZURES

ORGANON 对部分性癫痫发作患者的研究

• 批准号: 3668915
• 负责人: DAVID M TREIMAN
• 金额: $ 4.82万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 1986
• 资助国家: 美国
• 起止时间: 1986-05-01 至 1987-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3668915
• 关键词: anticonvulsants; drug adverse effect; human subject; human therapy evaluation; neuromuscular disorder chemotherapy; partial seizure; patient /disease registry

Conduct an early Phase II study of Flunarizine (ADD 59076) that follows a final protocol jointly agreed upon by the NINCDS, Janssen Pharmaceutica, Inc., and the contractor. The study will obtain preliminary information regarding the tolerability and metabolism of Flunarizine in three groups of patients with partial seizures.

开展氟桂利嗪（ADD 59076）的早期II期研究